Loading...

COMPASS Pathways plc

CMPS•NASDAQ
Healthcare
Medical - Care Facilities
$4.33
$-0.04(-0.92%)

COMPASS Pathways plc (CMPS) Company Profile & Overview

Explore COMPASS Pathways plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

COMPASS Pathways plc (CMPS) Company Profile & Overview

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

SectorHealthcare
IndustryMedical - Care Facilities
CEOKabir Kumar Nath

Contact Information

https://compasspathways.com
44 64 6905 3974
33 Broadwick Street, London, W1F 0DQ

Company Facts

166 Employees
IPO DateSep 18, 2020
CountryGB
Actively Trading

Frequently Asked Questions

;